Semen Analysis After Proton Therapy for Prostate Cancer



Status:Completed
Conditions:Prostate Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:March 2010
End Date:July 2015

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Semen Analysis Following Definitive Treatment of Prostate Cancer With Proton Radiation Therapy Alone

The purpose of this study is to evaluate semen for changes following treatment with proton
radiation therapy.


Inclusion Criteria:

- Diagnosis of low to intermediate risk prostate cancer and elected to have proton
radiation therapy at University of Florida Proton Therapy Institute (UFPTI).

Exclusion Criteria:

- Current use of Flomax, Hytrin, Cardura, Uroxatral, or Rapaflo.

- History of vasectomy.

- Current use of Lupron, Zoladex, Trelstar, Casodex, Eulexin.

- Current use of Avodart or Proscar.
We found this trial at
1
site
University of Florida Proton Therapy Institute
2015 Jefferson St
Jacksonville, Florida 32206
(904) 588-1800
University of Florida Proton Therapy Institute When the University of Florida Proton Therapy Institute opened...
?
mi
from
Jacksonville, FL
Click here to add this to my saved trials